P&G Health is currently trading at Rs. 4262.00, up by 6.00 points or 0.14% from its previous closing of Rs. 4256.00 on the BSE.
The scrip opened at Rs. 4270.35 and has touched a high and low of Rs. 4293.00 and Rs. 4252.45 respectively. So far 219 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 5120.80 on 29-Jul-2019 and a 52 week low of Rs. 2786.50 on 11-Dec-2018.
Last one week high and low of the scrip stood at Rs. 4395.00 and Rs. 4236.35 respectively. The current market cap of the company is Rs. 7058.80 crore.
The promoters holding in the company stood at 51.82%, while Institutions and Non-Institutions held 14.06% and 34.13% respectively.
Procter & Gamble Health (P&G Health) has launched ‘Panache’- a first of its kind platform to support India’s Gen X doctors in their medical education journey. Panache aims to assist students in honing crucial skills for holistic patient care viz. medico-legal aspects, ethics, role of technology, emotional intelligence, decision making, good communication, teamwork, problem solving and leadership among others.
P&G Health (formerly Merck) operates both its pharmaceuticals and chemicals businesses in the country. Merck was also the first Merck Group Company to go public in the year 1981.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1525.00 |
Dr. Reddys Lab | 5942.65 |
Cipla | 1345.35 |
Zydus Lifesciences | 925.95 |
Lupin | 1547.05 |
View more.. |